139 related articles for article (PubMed ID: 17785307)
1. Comparison of two ELISA assays for anti-Sp100 determination.
Manuel Lucena J; Montes Cano M; Luis Caro J; Respaldiza N; Alvarez A; Sánchez-Román J; Núñez-Roldán A; Wichmann I
Ann N Y Acad Sci; 2007 Aug; 1109():203-11. PubMed ID: 17785307
[TBL] [Abstract][Full Text] [Related]
2. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of anti-multiple nuclear dots/Sp100 autoantibodies.
Wichmann I; Montes-Cano MA; Respaldiza N; Alvarez A; Walter K; Franco E; Sanchez-Roman J; Núñez-Roldán A
Scand J Gastroenterol; 2003 Sep; 38(9):996-9. PubMed ID: 14531539
[TBL] [Abstract][Full Text] [Related]
4. PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis.
Granito A; Yang WH; Muratori L; Lim MJ; Nakajima A; Ferri S; Pappas G; Quarneti C; Bianchi FB; Bloch DB; Muratori P
Am J Gastroenterol; 2010 Jan; 105(1):125-31. PubMed ID: 19861957
[TBL] [Abstract][Full Text] [Related]
5. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis.
Liu H; Norman GL; Shums Z; Worman HJ; Krawitt EL; Bizzaro N; Vergani D; Bogdanos DP; Dalekos GN; Milkiewicz P; Czaja AJ; Heathcote EJ; Hirschfield GM; Tan EM; Miyachi K; Bignotto M; Battezzati PM; Lleo A; Leung PS; Podda M; Gershwin ME; Invernizzi P
J Autoimmun; 2010 Dec; 35(4):436-42. PubMed ID: 20932720
[TBL] [Abstract][Full Text] [Related]
6. Analysis of a multiple nuclear dots pattern in a large cohort of dermatological patients.
Cozzani E; Drosera M; Riva S; Parodi A
Clin Lab; 2012; 58(3-4):329-32. PubMed ID: 22582508
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis.
Mytilinaiou MG; Meyer W; Scheper T; Rigopoulou EI; Probst C; Koutsoumpas AL; Abeles D; Burroughs AK; Komorowski L; Vergani D; Bogdanos DP
Clin Chim Acta; 2012 Aug; 413(15-16):1211-6. PubMed ID: 22503841
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis.
Züchner D; Sternsdorf T; Szostecki C; Heathcote EJ; Cauch-Dudek K; Will H
Hepatology; 1997 Nov; 26(5):1123-30. PubMed ID: 9362351
[TBL] [Abstract][Full Text] [Related]
9. Detection of anti-SP100 antibodies in primary biliary cirrhosis. Comparison of ELISA and immunofluorescence.
Bauer A; Habior A; Kraszewska E
J Immunoassay Immunochem; 2013; 34(4):346-55. PubMed ID: 23859785
[TBL] [Abstract][Full Text] [Related]
10. [Anti-Sp100 and anti-Gp210 in the diagnosis of primary biliary cirrhosis in patients with autoimmune cholangitis].
Romero Gómez M; Wichmann I; Otero Fernández MA; Suárez García E; Grande L; Núñez J; Nevado Santos M; Castro Fernández M
Gastroenterol Hepatol; 1999 Jan; 22(1):11-3. PubMed ID: 10089705
[TBL] [Abstract][Full Text] [Related]
11. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease.
Milkiewicz P; Buwaneswaran H; Coltescu C; Shums Z; Norman GL; Heathcote EJ
Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1355-60. PubMed ID: 19631286
[TBL] [Abstract][Full Text] [Related]
12. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
[TBL] [Abstract][Full Text] [Related]
14. Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis.
Cavazzana I; Ceribelli A; Taraborelli M; Fredi M; Norman G; Tincani A; Satoh M; Franceschini F
J Rheumatol; 2011 Oct; 38(10):2180-5. PubMed ID: 21921093
[TBL] [Abstract][Full Text] [Related]
15. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens.
Miyakawa H; Tanaka A; Kikuchi K; Matsushita M; Kitazawa E; Kawaguchi N; Fujikawa H; Gershwin ME
Hepatology; 2001 Aug; 34(2):243-8. PubMed ID: 11481607
[TBL] [Abstract][Full Text] [Related]
16. Clinical correlation of antimitochondrial antibodies.
Zuber MA; Recktenwald C
Eur J Med Res; 2003 Feb; 8(2):61-70. PubMed ID: 12626283
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of antibody expressions in primary biliary cirrhosis and autoimmune cholangitis using phage display.
Ikuno N; Scealy M; Davies JM; Whittingham SF; Omagari K; Mackay IR; Rowley MJ
Hepatology; 2001 Sep; 34(3):478-86. PubMed ID: 11526532
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis.
Han E; Jo SJ; Lee H; Choi AR; Lim J; Jung ES; Oh EJ
Clin Chim Acta; 2017 Jan; 464():113-117. PubMed ID: 27864100
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic value of anti-mitochondrial antibodies, especially in primary biliary cirrhosis.
Tanaka A; Miyakawa H; Luketic VA; Kaplan M; Storch WB; Gershwin ME
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):295-9. PubMed ID: 12030434
[TBL] [Abstract][Full Text] [Related]
20. Small ubiquitin-related modifiers: A novel and independent class of autoantigens in primary biliary cirrhosis.
Janka C; Selmi C; Gershwin ME; Will H; Sternsdorf T
Hepatology; 2005 Mar; 41(3):609-16. PubMed ID: 15726652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
